Inactive/Delisted stock
Enveric Biosciences Stock (NASDAQ:ENVB)
Previous Close
$1.23
52W Range
$1.01 - $173.25
50D Avg
$1.27
200D Avg
$42.81
Market Cap
$3.09M
Avg Vol (3M)
$217.32K
Beta
0.32
Div Yield
-
ENVB Company Profile
Enveric Biosciences, Inc., a pharmaceutical company, engages in developing various cannabinoid medicines for cancer care. Its products pipeline includes EV104 for the treatment of osteoarthritis; EVM-101 and EVM-201 for the treatment of cancer related distress; EVM-301 for the treatment of mental health indication; EV102, a cannabinoid cream for topical skin application; and EV101, a cannabinoid and chemotherapy combination therapy. Enveric Biosciences, Inc. is headquartered in Naples, Florida.